What are the echocardiographic criteria for grading aortic regurgitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Echocardiographic Grading of Aortic Regurgitation

Aortic regurgitation severity is graded using an integrative approach combining qualitative, semi-quantitative, and quantitative echocardiographic parameters, with vena contracta width and effective regurgitant orifice area serving as the primary quantitative measures. 1

Severity Classification Criteria

Mild Aortic Regurgitation

  • Vena contracta (VC) width: <3 mm
  • Effective regurgitant orifice area (EROA): <10 mm²
  • Regurgitant volume (R Vol): <30 mL
  • Pressure half-time (PHT): >500 ms
  • Colour flow jet: Small central jet
  • Continuous wave (CW) Doppler signal: Incomplete/faint
  • Descending aorta flow: Brief protodiastolic flow reversal only
  • Abdominal aorta flow: Absent diastolic flow reversal 1

Moderate Aortic Regurgitation

This category is subdivided into two groups:

  • Mild-to-moderate: EROA 10-19 mm² or R Vol 30-44 mL
  • Moderate-to-severe: EROA 20-29 mm² or R Vol 45-59 mL
  • VC width: Intermediate (3-6 mm)
  • PHT: Intermediate (200-500 ms)
  • Colour flow jet: Intermediate size
  • CW Doppler signal: Dense
  • Descending aorta flow: Intermediate diastolic flow reversal 1

Severe Aortic Regurgitation

  • Vena contracta width: ≥6 mm
  • EROA: ≥30 mm²
  • Regurgitant volume: ≥60 mL
  • Pressure half-time: <200 ms
  • Colour flow jet: Large in central jets (variable in eccentric jets)
  • Jet width ratio: >65% of LVOT diameter
  • CW Doppler signal: Dense
  • Descending aorta flow: Holodiastolic flow reversal with end-diastolic velocity >20 cm/s
  • Abdominal aorta flow: Present diastolic flow reversal
  • Valve morphology: Abnormal/flail/large coaptation defect 1

Recommended Assessment Algorithm

Step 1: Qualitative Assessment

Begin with valve morphology and color Doppler assessment from multiple views (parasternal long-axis, parasternal short-axis, apical five-chamber). Color flow jet area alone should NOT be used to quantify AR severity 1. A flail leaflet or large coaptation defect immediately suggests severe AR.

Step 2: Semi-Quantitative Parameters

  • Vena contracta measurement (parasternal long-axis view, Nyquist limit 50-60 cm/s): This is relatively quick, independent of hemodynamic factors, and works well for eccentric jets 1
  • Pressure half-time from continuous wave Doppler (apical five-chamber view)
  • Descending aorta flow assessment from suprasternal notch view 1

Step 3: Quantitative Parameters (when feasible)

  • PISA method to calculate EROA and regurgitant volume
  • Volumetric method using stroke volume difference between LVOT and mitral inflow 1

Step 4: Supportive Findings

  • Left ventricular dimensions: LV dilatation supports chronic severe AR (end-diastolic diameter >56 mm, end-systolic diameter >40 mm)
  • Note: In acute severe AR, LV size is often normal 1

Critical Technical Considerations

Nyquist limit setting: Use 50-60 cm/s for vena contracta and color Doppler assessment 1

Common pitfalls to avoid:

  • Eccentric jets can be underestimated by color Doppler jet area due to Coanda effect (jet adherence to walls) 1
  • Pressure half-time is affected by LV compliance, blood pressure, acuteness of AR, and aortic compliance—shortened with increased LV diastolic pressure or vasodilator therapy 1
  • Vena contracta measurement errors are magnified due to small absolute values 1
  • PISA method has limited feasibility with heavy aortic valve calcification 1

When Parameters Are Discordant

When quantitative parameters conflict with clinical presentation, use adjunctive parameters and consider cardiac MRI 1. The recent research suggests that vena contracta demonstrates the strongest prognostic relevance for predicting need for surgical intervention 2, making it particularly valuable when other parameters are equivocal.

Integration is essential: No single parameter should be used in isolation. The European Association of Cardiovascular Imaging emphasizes that both VC measurement and PISA method are recommended when feasible, with supportive parameters used to resolve discordance 1.

Related Questions

What is the clinical significance of moderate aortic regurgitation on echocardiography?
Given an aortic regurgitation jet peak velocity of 4.95 m/s, left ventricular outflow tract (LVOT) diameter of 1.88 cm, and LVOT peak systolic velocity of 1.48 m/s, what is the severity of the aortic regurgitation and what is the appropriate management?
Does aortic regurgitation cause dizziness?
Can a transthoracic echocardiogram miss aortic regurgitation?
What left ventricular end‑diastolic and end‑systolic dimensions on echocardiography indicate surgical consideration in a patient with aortic regurgitation?
What is the appropriate approach and management for acute‑on‑chronic liver failure due to Wilson's disease in an 8‑year‑old child?
Please write a SOAP note for a patient presenting with acute periumbilical abdominal pain radiating to the right lower quadrant, onset 4 hours ago, rated 7/10, associated nausea, stable vital signs, mild RLQ tenderness with guarding, white blood cell count of 12,000 cells/µL, and normal serum lipase.
In a 60-year-old man with new bilateral mild background buzzing (tinnitus) for several weeks, what workup is indicated, what is the differential diagnosis, and does this symptom predict future hearing loss?
What is the recommended dosing, titration schedule, monitoring parameters, and contraindications for using topiramate in essential tremor?
What is the blood pressure monitoring protocol for Spravato (esketamine) nasal spray?
Is the new bilateral buzzing tinnitus in a 60-year-old man associated with Wegovy (semaglutide)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.